Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federico Diotallevi

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Dermatologic Therapy|August 29, 2022
Should we be concerned about gastrointestinal-related adverse events in patients with plaque psoriasis receiving secukinumab therapy? A retrospective, real-life studyFederico Diotallevi, Daisy Gambini, Giulia Radi, et al.
Skin Appendage Disorders|April 14, 2022
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of HallopeauGiulio Rizzetto, Federico Diotallevi, Elisa Molinelli, et al.
International Journal of Molecular Sciences|October 14, 2022
Biological Treatments for Pediatric Psoriasis: State of the Art and Future PerspectivesFederico Diotallevi, Oriana Simonetti, Giulio Rizzetto, et al.
Human Vaccines & Immunotherapeutics|June 25, 2021
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination managementOriana Simonetti, Giulia Radi, Elisa Molinelli, et al.
Healthcare (Basel, Switzerland)|November 27, 2021
Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult PatientsGiulia Radi, Oriana Simonetti, Giulio Rizzetto, et al.
Biomedicines|November 27, 2021
Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic ApproachesAnna Campanati, Andrea Marani, Emanuela Martina, et al.
Expert Opinion on Drug Safety|March 18, 2020
Safety update of etanercept treatment for moderate to severe plaque psoriasisAnna Campanati, Federico Diotallevi, Emanuela Martina, et al.
Biomedicines|November 11, 2022
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to BedsideGiulia Radi, Anna Campanti, Federico Diotallevi, et al.
Dermatologic Therapy|April 14, 2019
Pyoderma gangrenosum successfully treated with golimumab: Case report and review of the literatureFederico Diotallevi, Anna Campanati, Giulia Radi, et al.
Toxins|February 24, 2023
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative ReviewAnna Campanati, Federico Diotallevi, Giulia Radi, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Dermatologic Therapy|August 29, 2022
Should we be concerned about gastrointestinal-related adverse events in patients with plaque psoriasis receiving secukinumab therapy? A retrospective, real-life studyFederico Diotallevi, Daisy Gambini, Giulia Radi, et al.
Skin Appendage Disorders|April 14, 2022
Certolizumab Pegol: A New Therapeutic Approach for Acrodermatitis Continua of HallopeauGiulio Rizzetto, Federico Diotallevi, Elisa Molinelli, et al.
International Journal of Molecular Sciences|October 14, 2022
Biological Treatments for Pediatric Psoriasis: State of the Art and Future PerspectivesFederico Diotallevi, Oriana Simonetti, Giulio Rizzetto, et al.
Human Vaccines & Immunotherapeutics|June 25, 2021
Recommendations for dermatologists treating patients with atopic dermatitis during the Covid-19 pandemic: a look into the past for a conscious vaccination managementOriana Simonetti, Giulia Radi, Elisa Molinelli, et al.
Healthcare (Basel, Switzerland)|November 27, 2021
Baricitinib: The First Jak Inhibitor Approved in Europe for the Treatment of Moderate to Severe Atopic Dermatitis in Adult PatientsGiulia Radi, Oriana Simonetti, Giulio Rizzetto, et al.
Biomedicines|November 27, 2021
Psoriasis as an Immune-Mediated and Inflammatory Systemic Disease: From Pathophysiology to Novel Therapeutic ApproachesAnna Campanati, Andrea Marani, Emanuela Martina, et al.
Expert Opinion on Drug Safety|March 18, 2020
Safety update of etanercept treatment for moderate to severe plaque psoriasisAnna Campanati, Federico Diotallevi, Emanuela Martina, et al.
Biomedicines|November 11, 2022
A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to BedsideGiulia Radi, Anna Campanti, Federico Diotallevi, et al.
Dermatologic Therapy|April 14, 2019
Pyoderma gangrenosum successfully treated with golimumab: Case report and review of the literatureFederico Diotallevi, Anna Campanati, Giulia Radi, et al.
Toxins|February 24, 2023
Efficacy and Safety of Botulinum Toxin B in Focal Hyperhidrosis: A Narrative ReviewAnna Campanati, Federico Diotallevi, Giulia Radi, et al.
Pageof 6